OLMA
Olema Pharmaceuticals, Inc. Common StockRecent alerts on OLMA
All signals →
SEC filing
OLMA Reports Encouraging Phase 1 Data for OP-3136, KAT6 Inhibitor Shows Anti-Tumor Activity, Manageable Safety Profile
11d ago
News
Olema Pharmaceuticals GAAP EPS of -$0.52 beats by $0.01
21d ago
SEC filing
OLMA Reports $218.5M Offering Proceeds, $505.4M Cash, Palazestrant Phase 3 Data Fall 2026
78d ago
Scanner
Unusual buy pressure (5.4x avg, 74% up-volume, +6.9% / +1.11 intraday, above VWAP)
84d ago
Insider trade
Sale by Shawnte Mitchell (CHIEF LEGAL OFFICER)
88d ago
Insider trade
Sale by David C. Myles
104d ago
Insider trade
Sale by Shane William Charles Kovacs
104d ago
Insider trade
Sale by Cyrus Harmon
104d ago
Insider trade
Sale by Cyrus Harmon
104d ago
News
LifeSci Capital Reiterates a Buy on Olema Pharmaceuticals (OLMA)
123d ago
News
Olema Insider Sells $8 Million in Shares After 300% Stock Surge
144d ago
Failures to deliver
492,260 shares failed to deliver
150d ago
News
Olema Oncology Announces New Data from the Phase 1b/2 Trial of Palazestrant Plus Ribociclib in ER+/HER2- Metastatic Breast Cancer at ESMO 2025
153d ago
Insider trade
Sale by Zojwalla Naseem (Chief Medical Officer)
160d ago
Insider trade
Sale by Myles David C. (CH. DISCOV. & NON-CLIN DEV OFF)
160d ago
Insider trade
Sale by CLARK IAN T
160d ago
Get push alerts for OLMA
Add it to your watchlist in the app and receive every signal the moment it fires.
Download for iOS